Skip to content
Category: Press & Media
Inspirata AI Unveils Rebrand Backed by Two Decades of Cancer Registry Innovation and a Deepened Partnership with ONCO Inc.  

Inspirata AI Unveils Rebrand Backed by Two Decades of Cancer Registry Innovation and a Deepened Partnership with ONCO Inc.  

ONCO Inc. and Inspirata AI Inc. have formed a strategic partnership to advance oncology data management and support innovative cancer…

Sign up to receive Press & Media updates

Clinical Trials Guy's and St Thomas

Inspirata AI Partners with King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust to Evaluate the Application of AI Automation in Matching Patients with Cancer to Early Phase Clinical Trials

King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust will pilot Inspirata AI's Trial Navigator™.
Read More
Victorian Cancer Registry VCR

Inspirata AI Extends Multi-Year Partnership with the Victorian Cancer Registry

Inspirata AI announces a multi-year extension of its partnership with one of the world’s leading cancer registries, the Victorian Cancer Registry (VCR) in Australia.
Read More
Cord-19 NLP Inspirata

Inspirata AI Demonstrates How Its Clinically Optimized NLP Engine Excels in COVID-19 Disease Data Categorization and Other Healthcare Use Cases

Inspirata AI applied its Natural Language Processing (NLP) engine to help researchers extract clinical concepts that may be important for their projects on COVID-19. The company will hold a virtual
Read More
NLP On Demand Data Abstraction

Inspirata AI Launches Cloud-Based Cancer and Clinical Data Extraction Software Service

Leveraging the power of artificial intelligence and natural language processing, NLP On Demand standardizes patient data from clinical reports, identifies critical cancer information, determines the relevant context, and provides expert interpretation.
Read More
AI-in-Medicine

Inspirata AI Acquires Toronto-Based Artificial Intelligence in Medicine, Inc. (AIM) to Enhance its R&D in Artificial Intelligence and Natural Language Processing

The strategic acquisition enhances Inspirata AI’s R&D capability in Artificial Intelligence and Natural Language Processing, enabling it to offer its clients advanced capabilities to extract cancer data from narrative text
Read More